These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33590098)

  • 21. Bioinformatic analysis of type III CRISPR systems reveals key properties and new effector families.
    Hoikkala V; Graham S; White MF
    Nucleic Acids Res; 2024 Jul; 52(12):7129-7141. PubMed ID: 38808661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive search for accessory proteins encoded with archaeal and bacterial type III CRISPR-cas gene cassettes reveals 39 new cas gene families.
    Shah SA; Alkhnbashi OS; Behler J; Han W; She Q; Hess WR; Garrett RA; Backofen R
    RNA Biol; 2019 Apr; 16(4):530-542. PubMed ID: 29911924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An anti-CRISPR viral ring nuclease subverts type III CRISPR immunity.
    Athukoralage JS; McMahon SA; Zhang C; Grüschow S; Graham S; Krupovic M; Whitaker RJ; Gloster TM; White MF
    Nature; 2020 Jan; 577(7791):572-575. PubMed ID: 31942067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Type III-A CRISPR-Cas systems.
    Foster K; Kalter J; Woodside W; Terns RM; Terns MP
    RNA Biol; 2019 Apr; 16(4):449-460. PubMed ID: 29995577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The CRISPR effector Cam1 mediates membrane depolarization for phage defence.
    Baca CF; Yu Y; Rostøl JT; Majumder P; Patel DJ; Marraffini LA
    Nature; 2024 Jan; 625(7996):797-804. PubMed ID: 38200316
    [TBL] [Abstract][Full Text] [Related]  

  • 26. If You'd Like to Stop a Type III CRISPR Ribonuclease, Then You Should Put a Ring (Nuclease) on It.
    Mo CY; Marraffini LA
    Mol Cell; 2018 Nov; 72(4):608-609. PubMed ID: 30444997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure of Csx1-cOA
    Molina R; Stella S; Feng M; Sofos N; Jauniskis V; Pozdnyakova I; López-Méndez B; She Q; Montoya G
    Nat Commun; 2019 Sep; 10(1):4302. PubMed ID: 31541109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Type III-B Cmr effector complex catalyzes the synthesis of cyclic oligoadenylate second messengers by cooperative substrate binding.
    Han W; Stella S; Zhang Y; Guo T; Sulek K; Peng-Lundgren L; Montoya G; She Q
    Nucleic Acids Res; 2018 Nov; 46(19):10319-10330. PubMed ID: 30239876
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The diverse arsenal of type III CRISPR-Cas-associated CARF and SAVED effectors.
    Steens JA; Salazar CRP; Staals RHJ
    Biochem Soc Trans; 2022 Oct; 50(5):1353-1364. PubMed ID: 36282000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type III-A CRISPR-associated protein Csm6 degrades cyclic hexa-adenylate activator using both CARF and HEPN domains.
    Smalakyte D; Kazlauskiene M; F Havelund J; Rukšėnaitė A; Rimaite A; Tamulaitiene G; Færgeman NJ; Tamulaitis G; Siksnys V
    Nucleic Acids Res; 2020 Sep; 48(16):9204-9217. PubMed ID: 32766806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heavily Armed Ancestors: CRISPR Immunity and Applications in Archaea with a Comparative Analysis of CRISPR Types in Sulfolobales.
    Zink IA; Wimmer E; Schleper C
    Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33172134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
    Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
    Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyclic Tetra-Adenylate (cA
    Charbonneau AA; Eckert DM; Gauvin CC; Lintner NG; Lawrence CM
    Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease.
    Sheppard NF; Glover CV; Terns RM; Terns MP
    RNA; 2016 Feb; 22(2):216-24. PubMed ID: 26647461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the RNA and DNA nuclease activities required for Pyrococcus furiosus Type III-B CRISPR-Cas immunity.
    Foster K; Grüschow S; Bailey S; White MF; Terns MP
    Nucleic Acids Res; 2020 May; 48(8):4418-4434. PubMed ID: 32198888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23.
    Grüschow S; McQuarrie S; Ackermann K; McMahon S; Bode BE; Gloster TM; White MF
    Nucleic Acids Res; 2024 Apr; 52(6):2761-2775. PubMed ID: 38471818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ribosomal stalk-captured CARF-RelE ribonuclease inhibits translation following CRISPR signaling.
    Mogila I; Tamulaitiene G; Keda K; Timinskas A; Ruksenaite A; Sasnauskas G; Venclovas Č; Siksnys V; Tamulaitis G
    Science; 2023 Dec; 382(6674):1036-1041. PubMed ID: 38033086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The dynamic interplay of host and viral enzymes in type III CRISPR-mediated cyclic nucleotide signalling.
    Athukoralage JS; Graham S; Rouillon C; Grüschow S; Czekster CM; White MF
    Elife; 2020 Apr; 9():. PubMed ID: 32338598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The SAVED domain of the type III CRISPR protease CalpL is a ring nuclease.
    Binder SC; Schneberger N; Schmitz M; Engeser M; Geyer M; Rouillon C; Hagelueken G
    Nucleic Acids Res; 2024 Sep; 52(17):10520-10532. PubMed ID: 39166476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular basis of stepwise cyclic tetra-adenylate cleavage by the type III CRISPR ring nuclease Crn1/Sso2081.
    Du L; Zhang D; Luo Z; Lin Z
    Nucleic Acids Res; 2023 Mar; 51(5):2485-2495. PubMed ID: 36807980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.